PATENT CLAIM ANALYSIS

Application Number: 15997715
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "009322"]

Abstract:
A pharmaceutical composition includes a plurality of metal nanoparticles and at least one therapeutic agent. Each of the metal nanoparticles includes a core and a stabilizing agent coated on a surface of the core. The at least one therapeutic agent is attached to the stabilizing agent of the metal nanoparticles. Each of the therapeutic agent is an amphiphilic compound and has at least one hydrophobic chain interacting with the stabilizing agent. The pharmaceutical composition may further include a polymer shell encapsulating the metal nanoparticles and the therapeutic agent for enabling controlled release of the therapeutic agent. The pharmaceutical compositions are bifunctional and may be used for diagnosing and treating cancer. Methods for using the pharmaceutical compositions in conjunction with radiation therapy to diagnose and treat cancer are also provided.

Claim (Index 12):
The pharmaceutical composition of  claim 8 , further comprising an adaptor agent linking the therapeutic agent to the stabilizing agent of the metal nanoparticles.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 94.0
- Lexical Diversity: 2.15873
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14531466', '12322443', '13642868', '12928121', '11975279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7246451289965701
- 35 USC 102 Novelty (BERT): 0.4895062000719918
- Combined Prediction Score: 0.7011312361041123
- Mean Citation Score: 230.28542
- Max Citation Score: 236.21309
- Similarity Product: 183.09704303256987

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test